Understanding Ocular Surface Inflammation in Tears Before and After Autologous Cultivated Limbal Epithelial Stem Cell Transplantation

Abstract Introduction We aimed to determine the expression of inflammatory cytokines in the tears of patients with unilateral total limbal stem cell deficiency (TLSCD) caused by chemical burns before and after autologous cultivated limbal epithelial stem cell transplantation (CLET). Methods Tear sam...

Full description

Bibliographic Details
Main Authors: Gustavo S. Figueiredo, Jeffry Hogg, Arthur Okonkwo, Oliver J. Baylis, Monica Berry, Simi Ali, Majlinda Lako, Francisco C. Figueiredo
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-01-01
Series:Ophthalmology and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s40123-023-00656-6
_version_ 1827985002167533568
author Gustavo S. Figueiredo
Jeffry Hogg
Arthur Okonkwo
Oliver J. Baylis
Monica Berry
Simi Ali
Majlinda Lako
Francisco C. Figueiredo
author_facet Gustavo S. Figueiredo
Jeffry Hogg
Arthur Okonkwo
Oliver J. Baylis
Monica Berry
Simi Ali
Majlinda Lako
Francisco C. Figueiredo
author_sort Gustavo S. Figueiredo
collection DOAJ
description Abstract Introduction We aimed to determine the expression of inflammatory cytokines in the tears of patients with unilateral total limbal stem cell deficiency (TLSCD) caused by chemical burns before and after autologous cultivated limbal epithelial stem cell transplantation (CLET). Methods Tear samples were collected from both eyes of 23 patients with unilateral TLSCD and 11 healthy controls, at fixed timepoints before and after CLET. Dissolved molecules were extracted from Schirmer’s strips using a standardised method and analysed on an array plate of ten inflammatory cytokines (V-Plex Proinflammatory Panel 1 Human Kit, MSD). Results IL1β expression was significantly elevated in the TLSCD eye compared with the unaffected eye at baseline (p < 0.0001) but decreased to normal 3 months post-CLET (p = 0.22). IL6 and IL8 were unaffected at baseline but significantly elevated in the TLSCD eyes at 1 month post-CLET (p = 0.001 and p < 0.0001, respectively). IL6 returned to normal at 3 months and IL8 at 6 months post-CLET. There was a significant renewed increase in IL1β, IL6 and IL8 expression at 12 months post-CLET (p < 0.0001, p = 0.0001 and p = 0.0003, respectively). IFNγ, IL10 and IL12p70 expression were significantly reduced in both eyes of patients with unilateral TLSCD at all timepoints. Conclusion IL1β is a specific marker of inflammation in TLSCD eyes that could be therapeutically targeted pre-CLET to improve stem cell engraftment. At 12 months post-CLET the spike in levels of IL1β, IL6 and IL8 coincides with cessation of topical steroids, suggesting ongoing subclinical inflammation. We therefore recommend not discontinuing topical steroid treatment in cases where penetrating keratoplasty is indicated; however, further investigation is needed to ascertain this. Trial Registration European Union Drug Regulating Authorities Clinical Trials Database (EuDRACT 2011—000608-16); ISRCTN (International Standard Randomised Controlled Trial Number (isrctn51772481).
first_indexed 2024-04-09T23:07:53Z
format Article
id doaj.art-d0b2c15290dc4ad3a631d9375d0d28e3
institution Directory Open Access Journal
issn 2193-8245
2193-6528
language English
last_indexed 2024-04-09T23:07:53Z
publishDate 2023-01-01
publisher Adis, Springer Healthcare
record_format Article
series Ophthalmology and Therapy
spelling doaj.art-d0b2c15290dc4ad3a631d9375d0d28e32023-03-22T10:36:41ZengAdis, Springer HealthcareOphthalmology and Therapy2193-82452193-65282023-01-011221097110710.1007/s40123-023-00656-6Understanding Ocular Surface Inflammation in Tears Before and After Autologous Cultivated Limbal Epithelial Stem Cell TransplantationGustavo S. Figueiredo0Jeffry Hogg1Arthur Okonkwo2Oliver J. Baylis3Monica Berry4Simi Ali5Majlinda Lako6Francisco C. Figueiredo7Department of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation TrustDepartment of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation TrustDepartment of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation TrustDepartment of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation TrustHH Wills Physics Laboratory, University of BristolInstitute of Cellular Medicine, Newcastle UniversityFaculty of Medical Sciences, Biosciences Institute, Newcastle UniversityDepartment of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation TrustAbstract Introduction We aimed to determine the expression of inflammatory cytokines in the tears of patients with unilateral total limbal stem cell deficiency (TLSCD) caused by chemical burns before and after autologous cultivated limbal epithelial stem cell transplantation (CLET). Methods Tear samples were collected from both eyes of 23 patients with unilateral TLSCD and 11 healthy controls, at fixed timepoints before and after CLET. Dissolved molecules were extracted from Schirmer’s strips using a standardised method and analysed on an array plate of ten inflammatory cytokines (V-Plex Proinflammatory Panel 1 Human Kit, MSD). Results IL1β expression was significantly elevated in the TLSCD eye compared with the unaffected eye at baseline (p < 0.0001) but decreased to normal 3 months post-CLET (p = 0.22). IL6 and IL8 were unaffected at baseline but significantly elevated in the TLSCD eyes at 1 month post-CLET (p = 0.001 and p < 0.0001, respectively). IL6 returned to normal at 3 months and IL8 at 6 months post-CLET. There was a significant renewed increase in IL1β, IL6 and IL8 expression at 12 months post-CLET (p < 0.0001, p = 0.0001 and p = 0.0003, respectively). IFNγ, IL10 and IL12p70 expression were significantly reduced in both eyes of patients with unilateral TLSCD at all timepoints. Conclusion IL1β is a specific marker of inflammation in TLSCD eyes that could be therapeutically targeted pre-CLET to improve stem cell engraftment. At 12 months post-CLET the spike in levels of IL1β, IL6 and IL8 coincides with cessation of topical steroids, suggesting ongoing subclinical inflammation. We therefore recommend not discontinuing topical steroid treatment in cases where penetrating keratoplasty is indicated; however, further investigation is needed to ascertain this. Trial Registration European Union Drug Regulating Authorities Clinical Trials Database (EuDRACT 2011—000608-16); ISRCTN (International Standard Randomised Controlled Trial Number (isrctn51772481).https://doi.org/10.1007/s40123-023-00656-6Autologous limbal stem cell transplantCytokinesOcular surface inflammationLimbal stem cell deficiencyTears
spellingShingle Gustavo S. Figueiredo
Jeffry Hogg
Arthur Okonkwo
Oliver J. Baylis
Monica Berry
Simi Ali
Majlinda Lako
Francisco C. Figueiredo
Understanding Ocular Surface Inflammation in Tears Before and After Autologous Cultivated Limbal Epithelial Stem Cell Transplantation
Ophthalmology and Therapy
Autologous limbal stem cell transplant
Cytokines
Ocular surface inflammation
Limbal stem cell deficiency
Tears
title Understanding Ocular Surface Inflammation in Tears Before and After Autologous Cultivated Limbal Epithelial Stem Cell Transplantation
title_full Understanding Ocular Surface Inflammation in Tears Before and After Autologous Cultivated Limbal Epithelial Stem Cell Transplantation
title_fullStr Understanding Ocular Surface Inflammation in Tears Before and After Autologous Cultivated Limbal Epithelial Stem Cell Transplantation
title_full_unstemmed Understanding Ocular Surface Inflammation in Tears Before and After Autologous Cultivated Limbal Epithelial Stem Cell Transplantation
title_short Understanding Ocular Surface Inflammation in Tears Before and After Autologous Cultivated Limbal Epithelial Stem Cell Transplantation
title_sort understanding ocular surface inflammation in tears before and after autologous cultivated limbal epithelial stem cell transplantation
topic Autologous limbal stem cell transplant
Cytokines
Ocular surface inflammation
Limbal stem cell deficiency
Tears
url https://doi.org/10.1007/s40123-023-00656-6
work_keys_str_mv AT gustavosfigueiredo understandingocularsurfaceinflammationintearsbeforeandafterautologouscultivatedlimbalepithelialstemcelltransplantation
AT jeffryhogg understandingocularsurfaceinflammationintearsbeforeandafterautologouscultivatedlimbalepithelialstemcelltransplantation
AT arthurokonkwo understandingocularsurfaceinflammationintearsbeforeandafterautologouscultivatedlimbalepithelialstemcelltransplantation
AT oliverjbaylis understandingocularsurfaceinflammationintearsbeforeandafterautologouscultivatedlimbalepithelialstemcelltransplantation
AT monicaberry understandingocularsurfaceinflammationintearsbeforeandafterautologouscultivatedlimbalepithelialstemcelltransplantation
AT simiali understandingocularsurfaceinflammationintearsbeforeandafterautologouscultivatedlimbalepithelialstemcelltransplantation
AT majlindalako understandingocularsurfaceinflammationintearsbeforeandafterautologouscultivatedlimbalepithelialstemcelltransplantation
AT franciscocfigueiredo understandingocularsurfaceinflammationintearsbeforeandafterautologouscultivatedlimbalepithelialstemcelltransplantation